.png)
Endovascular Engineering (E2)
Endovascular Engineering, Inc. ("E2"), is a mission driven, venture-backed company focusing on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism.
Endovascular Engineering (E2)
Endovascular Engineering develops the Hēlo™ Thrombectomy System, a catheter-based technology for removing blood clots, primarily targeting pulmonary embolism treatment.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Advanced thrombectomy systems with smaller profiles and effective clot engagement mechanisms.
Integration capabilities with existing clinical workflows and imaging technologies.
Next-generation clot removal technologies for venous thromboembolism and pulmonary embolism.
Service Requirements
Training and support for physicians using the Hēlo™ system.
Consulting services for navigating regulatory approval processes.
Potential customer support needs as the company grows.
Infrastructure Requirements
Cath labs equipped for endovascular procedures.
Data collection and storage infrastructure for clinical trials.
Cloud/hardware infrastructure to scale as the product nears commercialization
Talent Requirements
Clinical research expertise to manage and analyze trial data.
Regulatory affairs specialists to navigate FDA approval processes.
Sales and marketing professionals for commercializing the Hēlo™ system.
Engineers and scientists for ongoing product development and innovation.
AI Insights
Growth Trajectory
Endovascular Engineering demonstrates significant growth potential as they advance the Hēlo™ PE Thrombectomy System through clinical trials, with the prospect of commercialization and market expansion upon regulatory approval.
Market Opportunity
Endovascular Engineering has a strong market opportunity in addressing the need for more effective and less invasive thrombectomy solutions, particularly for pulmonary embolism, pending successful clinical trials and regulatory approval.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats